BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Authors » Katie Pfaff

Articles by Katie Pfaff

Zeiss acquires Veracity to speed answers to doctors during eye care procedures

Aug. 23, 2017
By Katie Pfaff
Carl Zeiss Meditech AG brings better efficiency and data to ophthalmologists during cataract surgery with its acquisition of Veracity Innovations LLC, a cloud-based platform company designed to increase results for clinicians. Clinical data and treatment information will be immediately available to physicians. Details of the acquisition were not disclosed.
Read More

FDA plasma panel to aid in standardizing Zika detection

Aug. 22, 2017
By Katie Pfaff

Endologix reports positive outcomes in ongoing study

Aug. 18, 2017
By Katie Pfaff

Venturemed closes $15M series B for Flex PAD portfolio

Aug. 17, 2017
By Katie Pfaff

Tandem launches pivotal trial for insulin pump, low blood sugar prediction technology

Aug. 16, 2017
By Katie Pfaff

MDxhealth study points to promising prostate cancer risk-screening tool

Aug. 15, 2017
By Katie Pfaff
An August study finds MDxhealth SA may have an effective tool in determining risk for prostate cancer with its ConfirmMDx screening. Aggressive prostate cancer (PCa) risk has historically been difficult to pinpoint, leading to false positives and unneeded treatment, as well as men who have cancer that biopsy did not detect.
Read More

Apollo endosurgery clarifies FDA letter on intragastric balloon safety

Aug. 14, 2017
By Katie Pfaff
Following an FDA letter issued Thursday Aug. 10 to health care providers about possible risks with liquid-filled intragastric balloons, Apollo Endosurgery Inc. held a call on Friday to address the letter. During the call, executives with Apollo, maker of the Orbera intragastric balloon system, discussed the FDA letter regarding unexpected deaths of five patients who had received the balloons, though their deaths were not determined to be the result of the devices, said the company.
Read More

Neosync raises $13M for Nest home-based depression device

Aug. 11, 2017
By Katie Pfaff

Bionik Arke exoskeleton gains voice control with Alexa, Echo

Aug. 10, 2017
By Katie Pfaff
Robotics firm Bionik Laboratories Corp. has updated its Arke exoskeleton with Amazon's Echo and Alexa. Patients can ask the system to stand or walk to activate Arke.
Read More

Optovue receives FDA nod for eye health indicator

Aug. 9, 2017
By Katie Pfaff
Previous 1 2 … 14 15 16 17 18 19 20 21 22 23 24 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing